Anti-NNMT Antibody

Produced by Antibodies.com and distributed through AFMS, this polyclonal primary antibody is raised in rabbit and specifically targets Nicotinamide N-methyltransferase (NNMT, also known as Nicotinamide N-Methyltransferase). Each vial is supplied at 50 µl volume at a working concentration of 1.0 mg/ml, presented in an unconjugated format so that investigators can freely pair the reagent with their preferred secondary detection systems. The antibody has been validated for use in two core immunoassays, namely Western Blot (WB) and Immunofluorescence (IF), and its reactivity profile is confirmed against human samples, making it well suited to studies of NNMT expression in human cell lines and tissue-derived material. As a polyclonal reagent, the antibody recognises multiple epitopes on the NNMT target, which generally translates into stronger signal and greater tolerance for minor conformational variation in the antigen. The product is certified for Research Use Only and is not intended for diagnostic or therapeutic applications, and it ships with a typical customer delivery window of around seven days. Provided at 50 µl per unit at 1.0 mg/ml, each vial offers ample reagent for routine blotting and immunofluorescence workflows, and the unconjugated, rabbit-host formulation integrates easily into standard laboratory protocols relying on anti-rabbit IgG secondary antibodies.